Chicken Pox Info
Sunday, January 29, 2023
  • Home
  • Chickenpox
  • Monkeypox
  • Cowpox
  • Goatpox
  • Horsepox
  • Sheeppox
  • Squirrelpox
No Result
View All Result
  • Home
  • Chickenpox
  • Monkeypox
  • Cowpox
  • Goatpox
  • Horsepox
  • Sheeppox
  • Squirrelpox
No Result
View All Result
Chicken Pox Info
No Result
View All Result
Home Monkeypox

CDC cautiously optimistic outbreak might be slowing

Chickenpox Info by Chickenpox Info
August 26, 2022
in Monkeypox
0
CDC cautiously optimistic outbreak might be slowing
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

RELATED POSTS

Consider 2 Safety Issues When Treating, Vaccinating for Monkeypox

Global Monkeypox Treatment Market to reach US$ 249 million by 2033, Tecovirimat to account for 61% of all Therapeutic Approaches: Future Market Insights, Inc.


The Centers for Disease Control and Prevention is cautiously optimistic that the U.S. is slowing the spread of monkeypox as new cases fall in several major cities.

“We’re watching this with cautious optimism, and really hopeful that many of our harm-reduction messages and our vaccines are getting out there and working,” CDC Director Dr. Rochelle Walensky told reporters Friday during an update on the monkeypox outbreak.

Although monkeypox cases are still increasing nationally, the speed of the outbreak appears to be slowing, Walensky said. The U.S. has reported nearly 17,000 monkeypox cases since May, more than any other country in the world, according to CDC data.

In New York City, which has reported more infections than any other jurisdiction, new monkeypox cases have dropped from more than 70 per day on average to nine as of Thursday, according to data from the city health department.

Dr. Aswhin Vasan, the city health commissioner, said earlier this week the outbreak has slowed due to increased vaccination and community outreach efforts. New York City has reported a total of 2,888 monkeypox cases.

In Chicago, another major epicenter of the outbreak, new cases have dropped from 141 during the week ended July 30 to 74 for the week ended Aug. 20, according to that city’s health department. Chicago has reported a total of 807 cases.

“We’re not seeing the potentially exponential growth that we were seeing early on so that is reassuring,” said Dr. Allison Arwady, Chicago’s public health commissioner, during a Facebook live event earlier this week. “Too early to say things look really good, but definitely some signs of slowing of cases.”

The U.S. is nearing the point where the entire community of gay and bisexual men who currently face the greatest health risk from monkeypox rwill have access to two doses of the monkeypox vaccine, according to Dawn O’Connell, head of the office responsible for the national stockpile at the Health and Human Services Department.

The CDC previously estimated that up to 1.7 million gay and bisexual men who are HIV-positive or are eligible for medicine to reduce their chance of contracting HIV face the greatest health risk from monkeypox.

The U.S. has distributed 1.5 million doses of the monkeypox vaccine so far and more than 3 million doses should be available by when the latest distribution round is complete, according to O’Connell.

To date, the outbreak is disproportionately affecting Black and Hispanic men. About 30% of monkeypox patients are white, 32% are Hispanic and 33% are Black, according to CDC data. Whites make up about 59% of the U.S. population while Hispanics and Blacks account for 19% and 13%, respectively.

The monkeypox vaccine, called Jynneos in the U.S., is administered in two doses 28 days apart. The patients will not have full protection from the vaccine until two weeks after the second dose is administered, according to the CDC. Data from 19 jurisdictions show that nearly 97% of the shots administered so far were first doses, according to Walensky.

About 94% of monkeypox cases are associated with sexual contact and nearly all of the people who have contracted the virus are men who have sex with men, according to Demetre Daskalakis, the deputy head of the White House monkeypox response team.

A CDC survey of 824 gay and bisexual men found that 48% respondents have reduced their number of sexual partners and 50% have reduced one-time sexual encounters during the current outbreak. A separate CDC study found that a 40% decrease in one-time sexual encounters would reduce the final percentage of gay and bisexual men infected with monkeypox by up to 31%.

“We’re actually seeing vaccine get out, behaviors change, harm-reduction messages being heard and implemented,” Walensky said. “And all of that working together to bend the curve.”

Correction: 33% of confirmed monkeypox cases are among Black Americans. A previous version of this story misstated the figure.

ShareTweetPin
Chickenpox Info

Chickenpox Info

Related Posts

Consider 2 Safety Issues When Treating, Vaccinating for Monkeypox

Consider 2 Safety Issues When Treating, Vaccinating for Monkeypox

by Chickenpox Info
January 27, 2023
0

Pharmacists should consider 2 critical safety issues when treating or vaccinating patients for monkeypox.First, it is vital to understand that...

Global Monkeypox Treatment Market to reach US$ 249 million by 2033, Tecovirimat to account for 61% of all Therapeutic Approaches: Future Market Insights, Inc.

Global Monkeypox Treatment Market to reach US$ 249 million by 2033, Tecovirimat to account for 61% of all Therapeutic Approaches: Future Market Insights, Inc.

by Chickenpox Info
January 27, 2023
0

Future Market Insights Global and Consulting Pvt. Ltd.Asia Pacific Monkeypox Treatment Market is projected to witness the fastest growth of...

Global Monkeypox Treatment Market to reach US$ 249 million

Global Monkeypox Treatment Market to reach US$ 249 million

by Chickenpox Info
January 27, 2023
0

DUBAI, United Arab Emirates, Jan. 26, 2023 (GLOBE NEWSWIRE) -- A recent Future Market Insights report on the monkeypox treatment...

Florida Health Orange County

DOH-Orange MPOX / Monkeypox Vaccination Update #12

by Chickenpox Info
January 26, 2023
0

Contact: Kent Donahue Kent.Donahue@flhealth.gov407-858-1418  ORLANDO, FL – The following update is provided to keep the community informed on the Florida Department...

Study: Clinical Testing of Pediatric Mpox Specimens: Unique Features and Challenges in a Low Prevalence Population. Image Credit: Dotted Yeti / Shutterstock

An evaluation of pediatric Mpox specimens

by Chickenpox Info
January 25, 2023
0

In a recent study posted to the medRxiv* preprint server, researchers in the United States performed the clinical evaluation of...

Next Post
Schizophrenia

Varicella-Zoster Virus (VZV) And Herpes Simplex Virus (HSV) Trigger Alzheimer’s Disease Occurrence

Eight suspected cases of lumpy skin disease in Pune district: officials

Eight suspected cases of lumpy skin disease in Pune district: officials

RECOMMENDED

Consider 2 Safety Issues When Treating, Vaccinating for Monkeypox

Consider 2 Safety Issues When Treating, Vaccinating for Monkeypox

January 27, 2023
Global Monkeypox Treatment Market to reach US$ 249 million

Global Monkeypox Treatment Market to reach US$ 249 million

January 27, 2023

MOST VIEWED

  • Can you catch chickenpox twice? How contagious is virus and symptoms explained

    How long does chickenpox last? When do symptoms go away, how long is it contagious – and is there treatment

    0 shares
    Share 0 Tweet 0
  • What happened to monkeypox? Answers to your most pressing questions.

    0 shares
    Share 0 Tweet 0
  • TikTok craze of using calamine lotion as makeup causing chickenpox treatment shortages, pharmacy warns

    0 shares
    Share 0 Tweet 0
  • Research finds link between chickenpox and Alzheimer’s

    0 shares
    Share 0 Tweet 0
  • Can monkeypox spread through contaminated food?

    0 shares
    Share 0 Tweet 0

Chicken Pox Info

Welcome to Chicken Pox Info, where you will get all the latest news about all the different pox diseases, to stay up to date, and to protect yourself.

CATEGORY

  • Chickenpox
  • Cowpox
  • Goatpox
  • Horsepox
  • Monkeypox
  • Sheeppox
  • Squirrelpox

Site Links

  • Home
  • About Us
  • Contact Us
  • Disclaimer
  • Privacy Policy
  • Terms & Conditions

Latest News

  • Consider 2 Safety Issues When Treating, Vaccinating for Monkeypox
  • Global Monkeypox Treatment Market to reach US$ 249 million
  • Global Monkeypox Treatment Market to reach US$ 249 million by 2033, Tecovirimat to account for 61% of all Therapeutic Approaches: Future Market Insights, Inc.

Copyright © 2022 Chickenpoxinfo.com | All Rights Reserved.

No Result
View All Result
  • Home
  • Chickenpox
  • Monkeypox
  • Cowpox
  • Goatpox
  • Horsepox
  • Sheeppox
  • Squirrelpox

Copyright © 2022 Chickenpoxinfo.com | All Rights Reserved.

What Are Cookies
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
Cookie SettingsAccept All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT